Black Rock Inc. Edgewise Therapeutics, Inc. Transaction History
Black Rock Inc.
- $4.35 Trillion
- Q2 2024
A detailed history of Black Rock Inc. transactions in Edgewise Therapeutics, Inc. stock. As of the latest transaction made, Black Rock Inc. holds 6,015,711 shares of EWTX stock, worth $200 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
6,015,711
Previous 5,167,006
16.43%
Holding current value
$200 Million
Previous $94.2 Million
14.96%
% of portfolio
0.0%
Previous 0.0%
Shares
13 transactions
Others Institutions Holding EWTX
# of Institutions
163Shares Held
97.8MCall Options Held
45.7KPut Options Held
13.1K-
Orbimed Advisors LLC San Diego, CA15MShares$500 Million6.52% of portfolio
-
Ra Capital Management, L.P. Boston, MA8.91MShares$296 Million2.42% of portfolio
-
Baker Bros. Advisors LP New York, NY5.84MShares$194 Million1.4% of portfolio
-
Novo Holdings Hellerup, G75.55MShares$185 Million10.36% of portfolio
-
Janus Henderson Group PLC London, X04.56MShares$152 Million0.06% of portfolio
About Edgewise Therapeutics, Inc.
- Ticker EWTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 63,171,700
- Market Cap $2.1B
- Description
- Edgewise Therapeutics, Inc., a biopharmaceutical company, develops small molecule therapies for musculoskeletal diseases. The Company's lead product candidate, EDG-5506, is an orally administered small molecule designed to address the root cause of dystrophinopathies including Duchenne muscular dystrophy and Becker muscular dystrophy which has c...